Pages that link to "Q54302476"

The following pages link to CTLA4-Ig restores rejection of MHC class-II mismatched allografts by disabling IL-2-expanded regulatory T cells. (Q54302476):

Displaying 31 items.

• Clearance of acute myeloid leukemia by haploidentical natural killer cells is improved using IL-2 diphtheria toxin fusion protein (Q33781150) (← links)
• Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates (Q33804736) (← links)
• IL-17A and IL-2-expanded regulatory T cells cooperate to inhibit Th1-mediated rejection of MHC II disparate skin grafts (Q35022593) (← links)
• IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment (Q35885490) (← links)
• Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates. (Q36389157) (← links)
• Lessons and limits of mouse models (Q37340373) (← links)
• T regulatory cells in childhood arthritis--novel insights (Q38167815) (← links)
• T-cell costimulatory blockade in organ transplantation (Q38168010) (← links)
• Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future? (Q38804454) (← links)
• T Cell Cosignaling Molecules in Transplantation (Q38837473) (← links)
• ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys (Q39419895) (← links)
• Anti-CD28 Antibody and Belatacept Exert Differential Effects on Mechanisms of Renal Allograft Rejection. (Q39782306) (← links)
• Inhibitory effects of belatacept on allospecific regulatory T-cell generation in humans (Q41822599) (← links)
• Cutting edge: Receptors for C3a and C5a modulate stability of alloantigen-reactive induced regulatory T cells. (Q41889471) (← links)
• CD4+ CD28-Negative Cells: Armed and Dangerous (Q42393633) (← links)
• Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice. (Q46122123) (← links)
• Mesenchymal stem cells control alloreactive CD8(+) CD28(-) T cells (Q46134547) (← links)
• IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors (Q47099680) (← links)
• Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant (Q47952891) (← links)
• Regulatory T Cell-Dependent and -Independent Mechanisms of Immune Suppression by CD28/B7 and CD40/CD40L Costimulation Blockade (Q48204345) (← links)
• First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28. (Q48223745) (← links)
• Adoptive Cell Therapy with Tregs to Improve Transplant Outcomes: The Promise and the Stumbling Blocks (Q50632486) (← links)
• Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4+CTLA4hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade. (Q51742567) (← links)
• Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells: A Comparison Study of Anti-CD80/86 mAbs and CTLA4-lg Costimulatory Blockade (Q56886145) (← links)
• CD28/CTLA-4/B7 costimulatory pathway blockade affects regulatory T-cell function in autoimmunity (Q56895988) (← links)
• March1-dependent modulation of donor MHC II on CD103 dendritic cells mitigates alloimmunity (Q58699588) (← links)
• Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation (Q90044605) (← links)
• Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders (Q90241578) (← links)
• CTLA4Ig Improves Murine iTreg Induction via TGFβ and Suppressor Function In Vitro (Q90601868) (← links)
• Treg-mediated prolonged survival of skin allografts without immunosuppression (Q92732196) (← links)
• Engineering immunomodulatory biomaterials for type 1 diabetes (Q96951726) (← links)